688073 毕得医药
开盘竞价 02-27 09:30:00
资讯
新帖
简况
毕得医药（688073）披露股东权益变动触及1%刻度的提示性公告，2月24日股价下跌0.72%
证券之星 · 02-24 18:47
毕得医药（688073）披露股东权益变动触及1%刻度的提示性公告，2月24日股价下跌0.72%
每周股票复盘：毕得医药（688073）现多笔折价大宗交易
中金财经 · 02-15
每周股票复盘：毕得医药（688073）现多笔折价大宗交易
2月12日毕得医药现1笔折价18.81%的大宗交易 合计成交1151.04万元
证券之星 · 02-12
2月12日毕得医药现1笔折价18.81%的大宗交易 合计成交1151.04万元
2月11日毕得医药现1笔折价20.89%的大宗交易 合计成交296.82万元
证券之星 · 02-11
2月11日毕得医药现1笔折价20.89%的大宗交易 合计成交296.82万元
2月9日毕得医药发生2笔大宗交易 成交金额475.2万元
证券之星 · 02-09
2月9日毕得医药发生2笔大宗交易 成交金额475.2万元
每周股票复盘：毕得医药（688073）现多笔折价大宗交易
证券之星 · 02-08
每周股票复盘：毕得医药（688073）现多笔折价大宗交易
股市必读：2月5日毕得医药现400.74万元大宗交易
证券之星 · 02-06
股市必读：2月5日毕得医药现400.74万元大宗交易
股市必读：2月2日毕得医药现1笔折价17.64%的大宗交易 合计成交206.88万元
证券之星 · 02-03
股市必读：2月2日毕得医药现1笔折价17.64%的大宗交易 合计成交206.88万元
每周股票复盘：毕得医药（688073）审议修订董高薪酬制度
证券之星 · 02-01
每周股票复盘：毕得医药（688073）审议修订董高薪酬制度
毕得医药拟修订董高薪酬制度，强化激励约束机制
中金财经 · 01-31
毕得医药拟修订董高薪酬制度，强化激励约束机制
毕得医药（688073）披露2026年第一次临时股东会会议资料，1月30日股价下跌9.04%
证券之星 · 01-30
毕得医药（688073）披露2026年第一次临时股东会会议资料，1月30日股价下跌9.04%
1月30日毕得医药跌9.04%，信澳健康中国混合A基金重仓该股
证券之星 · 01-30
1月30日毕得医药跌9.04%，信澳健康中国混合A基金重仓该股
每周股票复盘：毕得医药（688073）戴岚减持计划完成持股降至32.48%
证券之星 · 01-25
每周股票复盘：毕得医药（688073）戴岚减持计划完成持股降至32.48%
上海毕得医药董事会提名委员会工作细则出炉，规范董事及高管选任
中金财经 · 01-24
上海毕得医药董事会提名委员会工作细则出炉，规范董事及高管选任
毕得医药（688073）披露股东减持计划完成暨减持股份结果公告，1月23日股价上涨2.02%
证券之星 · 01-23
毕得医药（688073）披露股东减持计划完成暨减持股份结果公告，1月23日股价上涨2.02%
毕得医药：1月21日至1月22日高管戴岚减持股份合计3.43万股
证券之星 · 01-22
毕得医药：1月21日至1月22日高管戴岚减持股份合计3.43万股
每周股票复盘：毕得医药（688073）高管戴岚两日合计减持8万股
证券之星 · 01-18
每周股票复盘：毕得医药（688073）高管戴岚两日合计减持8万股
毕得医药：1月13日高管戴岚减持股份合计3万股
证券之星 · 01-13
毕得医药：1月13日高管戴岚减持股份合计3万股
1月13日毕得医药涨5.28%，兴业医疗保健混合A基金重仓该股
证券之星 · 01-13
1月13日毕得医药涨5.28%，兴业医疗保健混合A基金重仓该股
毕得医药：1月12日高管戴岚减持股份合计5万股
证券之星 · 01-12
毕得医药：1月12日高管戴岚减持股份合计5万股
加载更多
公司概况
公司名称：
上海毕得医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-10-11
主营业务：
上海毕得医药科技股份有限公司的主营业务是为新药研发机构提供专业、高效的药物分子砌块及科学试剂产品及服务。公司的主要产品是分子砌块杂环化合物、分子砌块苯环化合物、分子砌块脂肪族类化合物、催化剂和配体、活性小分子化合物。
发行价格：
88.00
{"stockData":{"symbol":"688073","market":"SH","secType":"STK","nameCN":"毕得医药","latestPrice":58.46,"timestamp":1772155368000,"preClose":57.78,"halted":0,"volume":0,"delay":0,"changeRate":0.0118,"floatShares":43234200,"shares":90882900,"eps":1.6869,"marketStatus":"开盘竞价","change":0.68,"latestTime":"02-27 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":58.46,"askSize":23,"bidPrice":58.46,"bidSize":23,"shortable":0,"etf":0,"ttmEps":1.6869,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772155800000},"marketStatusCode":1,"adr":0,"adjPreClose":57.78,"symbolType":"stock_kcb","openAndCloseTimeList":[[1772155800000,1772163000000],[1772168400000,1772175600000]],"highLimit":63.56,"lowLimit":52,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":90882948,"isCdr":false,"pbRate":2.62,"roa":"--","peRate":34.655285,"roe":"5.93%","epsLYR":1.32,"committee":-0.08,"marketValue":5313000000,"turnoverRate":0,"status":0,"floatMarketCap":2527000000},"requestUrl":"/m/hq/s/688073","defaultTab":"news","newsList":[{"id":"2613379741","title":"毕得医药（688073）披露股东权益变动触及1%刻度的提示性公告，2月24日股价下跌0.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613379741","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613379741?lang=zh_cn&edition=full","pubTime":"2026-02-24 18:47","pubTimestamp":1771930033,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，毕得医药报收于59.29元，较前一交易日下跌0.72%，最新总市值为53.88亿元。该股当日开盘60.19元，最高60.47元，最低59.05元，成交额达5055.12万元，换手率为1.96%。公司于近日披露《关于股东权益变动触及1%刻度的提示性公告》。本次权益变动后，信息披露义务人合计持股比例由10.00%减少至8.83%，触及1%刻度。本次减持为履行已披露的减持计划，不触及要约收购，未违反相关承诺，不影响公司治理结构及实际控制人稳定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400037681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2611670144","title":"每周股票复盘：毕得医药（688073）现多笔折价大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2611670144","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611670144?lang=zh_cn&edition=full","pubTime":"2026-02-15 08:04","pubTimestamp":1771113893,"startTime":"0","endTime":"0","summary":"h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2026年2月13日收盘，毕得医药报收于59.72元，较上周的61.55元下跌2.97%。本周，毕得医药2月9日盘中最高价报62.69元。股本股东变化：2月13日公告，舟山欣曦、舟山兰旦合计减持106.47万股，占总股本1.1714%。公司公告汇总：2026年2月2日至12日，信息披露义务人持股比例由10.00%降至8.83%，触及1%刻度。2月12日毕得医药现1笔折价18.81%的大宗交易，合计成交1151.04万元。 2月9日毕得医药发生2笔大宗交易，成交金额475.2万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260215/32019273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2610894997","title":"2月12日毕得医药现1笔折价18.81%的大宗交易 合计成交1151.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610894997","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610894997?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:42","pubTimestamp":1770889347,"startTime":"0","endTime":"0","summary":"证券之星消息，2月12日毕得医药发生大宗交易，交易数据如下：大宗交易成交价格49.2元，相对当日收盘价折价18.81%，成交23.4万股，成交金额1151.04万元，买方营业部为长江证券股份有限公司成都人民南路证券营业部，卖方营业部为浙商证券股份有限公司上海长乐路证券营业部。近三个月该股共发生17笔大宗交易，合计成交1.19万手，折价成交17笔。截至2026年2月12日收盘，毕得医药报收于60.6元，下跌1.16%，换手率2.7%，成交量1.17万手，成交额7132.03万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200029018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2610098020","title":"2月11日毕得医药现1笔折价20.89%的大宗交易 合计成交296.82万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610098020","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610098020?lang=zh_cn&edition=full","pubTime":"2026-02-11 17:30","pubTimestamp":1770802250,"startTime":"0","endTime":"0","summary":"证券之星消息，2月11日毕得医药发生大宗交易，交易数据如下：大宗交易成交价格48.5元，相对当日收盘价折价20.89%，成交6.12万股，成交金额296.82万元，买方营业部为兴业证券股份有限公司上海金陵东路证券营业部，卖方营业部为浙商证券股份有限公司上海长乐路证券营业部。近三个月该股共发生23笔大宗交易，合计成交1.5万手，折价成交23笔。截至2026年2月11日收盘，毕得医药报收于61.31元，上涨1.57%，换手率3.56%，成交量1.54万手，成交额9369.07万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100027879.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2610635380","title":"2月9日毕得医药发生2笔大宗交易 成交金额475.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610635380","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610635380?lang=zh_cn&edition=full","pubTime":"2026-02-09 17:32","pubTimestamp":1770629560,"startTime":"0","endTime":"0","summary":"证券之星消息，2月9日毕得医药发生大宗交易，交易数据如下：近三个月该股共发生22笔大宗交易，合计成交1.44万手，折价成交22笔。该股近期无解禁股上市。截至2026年2月9日收盘，毕得医药(688073)报收于61.36元，下跌0.31%，换手率2.14%，成交量9256.0手，成交额5733.22万元。该股近半年内有股东持股变动，合计净减持102.24万股，股东增减持明细如下表：该股最近90天内共有2家机构给出评级，买入评级2家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020900022482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2609152686","title":"每周股票复盘：毕得医药（688073）现多笔折价大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2609152686","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609152686?lang=zh_cn&edition=full","pubTime":"2026-02-08 02:28","pubTimestamp":1770488892,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，毕得医药报收于61.55元，较上周的59.86元上涨2.82%。本周，毕得医药2月4日盘中最高价报63.8元。2月2日盘中最低价报58.28元。毕得医药当前最新总市值55.94亿元，在医疗服务板块市值排名32/51，在两市A股市值排名3216/5186。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2609588443","title":"股市必读：2月5日毕得医药现400.74万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2609588443","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609588443?lang=zh_cn&edition=full","pubTime":"2026-02-06 01:38","pubTimestamp":1770313089,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，毕得医药报收于61.58元，下跌1.94%，换手率2.17%，成交量9364.0手，成交额5833.2万元。来自交易信息汇总：同日发生400.74万元大宗交易，显示存在一定规模的机构或大户间交易行为。交易信息汇总资金流向2月5日主力资金净流出857.9万元，占总成交额14.71%；游资资金净流入907.87万元，占总成交额15.56%；散户资金净流出49.97万元，占总成交额0.86%。大宗交易2月5日毕得医药现400.74万元大宗交易。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600001426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2608941458","title":"股市必读：2月2日毕得医药现1笔折价17.64%的大宗交易 合计成交206.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608941458","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608941458?lang=zh_cn&edition=full","pubTime":"2026-02-03 02:57","pubTimestamp":1770058629,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，毕得医药报收于58.28元，下跌2.64%，换手率3.88%，成交量1.68万手，成交额9927.66万元。当日关注点来自交易信息汇总：2月2日毕得医药获主力资金净流入64.21万元，游资资金净流入480.73万元。大宗交易2月2日毕得医药现1笔折价17.64%的大宗交易，合计成交206.88万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300001747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2608077771","title":"每周股票复盘：毕得医药（688073）审议修订董高薪酬制度","url":"https://stock-news.laohu8.com/highlight/detail?id=2608077771","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608077771?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:30","pubTimestamp":1769887833,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，毕得医药报收于59.86元，较上周的70.6元下跌15.21%。本周，毕得医药1月26日盘中最高价报72.2元。本周关注点公司公告汇总：审议《关于修订<董事、高级管理人员薪酬管理制度>的议案》公司公告汇总毕得医药：2026年第一次临时股东会会议资料上海毕得医药科技股份有限公司将于2026年2月9日召开2026年第一次临时股东会，审议《关于修订<董事、高级管理人员薪酬管理制度>的议案》。本次股东会由董事会召集，董事长戴岚主持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2607073042","title":"毕得医药拟修订董高薪酬制度，强化激励约束机制","url":"https://stock-news.laohu8.com/highlight/detail?id=2607073042","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607073042?lang=zh_cn&edition=full","pubTime":"2026-01-31 11:31","pubTimestamp":1769830266,"startTime":"0","endTime":"0","summary":"中访网数据 上海毕得医药科技股份有限公司于2026年1月24日发布公告，拟召开2026年第一次临时股东会，审议修订《董事、高级管理人员薪酬管理制度》的议案。该议案旨在规范公司董事及高级管理人员的薪酬管理，建立科学有效的激励与约束机制，以调动其积极性。议案已由公司第二届董事会第三十次会议审议通过。根据公告，本次临时股东会将于2026年2月9日上午9:30在上海市杨浦区公司会议室以现场结合网络投票的方式举行，网络投票通过上海证券交易所系统进行。会议将审议上述单一议案。此次制度修订是公司完善治理结构、优化高管激励体系的重要举措，预计将对公司长期人才稳定与战略执行产生积极影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260131/31989176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2607538042","title":"毕得医药（688073）披露2026年第一次临时股东会会议资料，1月30日股价下跌9.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607538042","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607538042?lang=zh_cn&edition=full","pubTime":"2026-01-30 23:16","pubTimestamp":1769786175,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，毕得医药报收于59.86元，较前一交易日下跌9.04%，最新总市值为54.4亿元。该股当日开盘65.68元，最高66.57元，最低58.03元，成交额达2.27亿元，换手率为8.64%。近日，毕得医药发布2026年第一次临时股东会会议资料公告。公告显示，公司将于2026年2月9日召开2026年第一次临时股东会，审议《关于修订<董事、高级管理人员薪酬管理制度>的议案》。本次股东会由董事会召集，董事长戴岚主持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000048196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2607846090","title":"1月30日毕得医药跌9.04%，信澳健康中国混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2607846090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607846090?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:35","pubTimestamp":1769762132,"startTime":"0","endTime":"0","summary":"证券之星消息，1月30日毕得医药跌9.04%创60日新低，收盘报59.86元，换手率8.64%，成交量3.73万手，成交额2.27亿元。重仓毕得医药的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为信达澳亚基金的信澳健康中国混合A。信澳健康中国混合A目前规模为4.09亿元，最新净值2.416，较上一交易日下跌1.02%，近一年上涨16.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000027847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2606320762","title":"每周股票复盘：毕得医药（688073）戴岚减持计划完成持股降至32.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606320762","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606320762?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:23","pubTimestamp":1769282590,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，毕得医药报收于70.6元，较上周的70.31元上涨0.41%。本周关注点股本股东变化：戴岚减持148,835股，减持计划已实施完毕，持股比例降至32.48%。股本股东变化高管增减持2026年1月21日至1月22日，公司董事、高级管理人员戴岚减持3.43万股，占总股本0.0377%。股东减持计划完成暨减持股份结果公告本次减持计划实施前，戴岚持有公司32.64%股份。因自身资金需要，其计划通过集中竞价减持不超过148,835股。减持后戴岚持股比例降至32.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2605284674","title":"上海毕得医药董事会提名委员会工作细则出炉，规范董事及高管选任","url":"https://stock-news.laohu8.com/highlight/detail?id=2605284674","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605284674?lang=zh_cn&edition=full","pubTime":"2026-01-24 09:19","pubTimestamp":1769217580,"startTime":"0","endTime":"0","summary":"中访网数据 上海毕得医药科技股份有限公司近日公布了其董事会提名委员会工作细则，旨在规范公司董事及高级管理人员的遴选与任命程序，进一步完善公司治理结构。根据细则，提名委员会由三名董事组成，其中独立董事占多数，并由独立董事担任主任委员。该细则自董事会决议通过之日起施行，其制定与实施有助于提升上海毕得医药公司治理的规范性与透明度，强化董事会决策的专业性与独立性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260124/31968984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2605409186","title":"毕得医药（688073）披露股东减持计划完成暨减持股份结果公告，1月23日股价上涨2.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605409186","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605409186?lang=zh_cn&edition=full","pubTime":"2026-01-23 23:09","pubTimestamp":1769180956,"startTime":"0","endTime":"0","summary":"近日，毕得医药披露《股东减持计划完成暨减持股份结果公告》。公告显示，本次减持计划实施前，戴岚持有毕得医药32.64%股份。因自身资金需要，戴岚计划通过集中竞价交易方式减持不超过148,835股，即不超过公司总股本的0.16%。截至2026年1月22日，戴岚已累计减持148,835股，减持价格区间为65.10至75.00元/股，减持总金额为10,344,897.74元，本次减持计划已实施完毕。减持后戴岚持股比例降至32.48%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300043796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2605495551","title":"毕得医药：1月21日至1月22日高管戴岚减持股份合计3.43万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605495551","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605495551?lang=zh_cn&edition=full","pubTime":"2026-01-22 20:01","pubTimestamp":1769083295,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月22日市场公开信息、上市公司公告及交易所披露数据整理，毕得医药最新董监高及相关人员股份变动情况：2026年1月21日至2026年1月22日公司董事,高级管理人员戴岚共减持公司股份3.43万股，占公司总股本为0.0377%。变动期间公司股价上涨3.92%，1月22日当日收盘报69.2元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200036411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2604496923","title":"每周股票复盘：毕得医药（688073）高管戴岚两日合计减持8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604496923","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604496923?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:02","pubTimestamp":1768676531,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，毕得医药报收于70.31元，较上周的69.35元上涨1.38%。本周关注点股本股东变化：董事戴岚1月12日减持5万股，占总股本0.055% 股本股东变化：董事戴岚1月13日减持3万股，占总股本0.033% 股本股东变化高管增减持2026年1月13日，公司董事、高级管理人员戴岚减持3.0万股，占公司总股本0.033%。当日股价上涨5.28%，收盘报72.93元。2026年1月12日，公司董事、高级管理人员戴岚减持5.0万股，占公司总股本0.055%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688073"],"gpt_icon":0},{"id":"2603110686","title":"毕得医药：1月13日高管戴岚减持股份合计3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603110686","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603110686?lang=zh_cn&edition=full","pubTime":"2026-01-13 20:02","pubTimestamp":1768305756,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月13日市场公开信息、上市公司公告及交易所披露数据整理，毕得医药最新董监高及相关人员股份变动情况：2026年1月13日公司董事,高级管理人员戴岚共减持公司股份3.0万股，占公司总股本为0.033%。变动期间公司股价上涨5.28%，1月13日当日收盘报72.93元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300037734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2603488505","title":"1月13日毕得医药涨5.28%，兴业医疗保健混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603488505","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603488505?lang=zh_cn&edition=full","pubTime":"2026-01-13 15:35","pubTimestamp":1768289740,"startTime":"0","endTime":"0","summary":"证券之星消息，1月13日毕得医药涨5.28%，收盘报72.93元，换手率5.65%，成交量2.44万手，成交额1.81亿元。重仓毕得医药的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共9家，其中持有数量最多的公募基金为兴业基金的兴业医疗保健混合A。兴业医疗保健混合A目前规模为2.61亿元，最新净值0.8825，较上一交易日上涨0.02%，近一年上涨41.45%。该公募基金现任基金经理为陈旭。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300020422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"gpt_icon":0},{"id":"2602142865","title":"毕得医药：1月12日高管戴岚减持股份合计5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602142865","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602142865?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:02","pubTimestamp":1768219353,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月12日市场公开信息、上市公司公告及交易所披露数据整理，毕得医药最新董监高及相关人员股份变动情况：2026年1月12日公司董事,高级管理人员戴岚共减持公司股份5.0万股，占公司总股本为0.055%。变动期间公司股价下跌0.12%，1月12日当日收盘报69.27元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200032619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688073","BK0216"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772155373893,"stockEarnings":[{"period":"1week","weight":-0.0325},{"period":"1month","weight":-0.1781},{"period":"3month","weight":-0.2058},{"period":"6month","weight":-0.139},{"period":"1year","weight":0.0585},{"period":"ytd","weight":-0.0536}],"compareEarnings":[{"period":"1week","weight":0.0158},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0664},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.2267},{"period":"ytd","weight":0.0448}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海毕得医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"3493人(较上一季度减少7.64%)","perCapita":"12377股","listingDate":"2022-10-11","address":"上海市杨浦区翔殷路128号11号楼A座101室","registeredCapital":"9088万元","survey":" 上海毕得医药科技股份有限公司的主营业务是为新药研发机构提供专业、高效的药物分子砌块及科学试剂产品及服务。公司的主要产品是分子砌块杂环化合物、分子砌块苯环化合物、分子砌块脂肪族类化合物、催化剂和配体、活性小分子化合物。","listedPrice":88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"毕得医药(688073)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供毕得医药(688073)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"毕得医药,688073,毕得医药股票,毕得医药股票老虎,毕得医药股票老虎国际,毕得医药行情,毕得医药股票行情,毕得医药股价,毕得医药股市,毕得医药股票价格,毕得医药股票交易,毕得医药股票购买,毕得医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"毕得医药(688073)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供毕得医药(688073)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}